Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Swedish Orphan Biovitrum    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM

(SOBI)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
08/19/2019 08/20/2019 08/21/2019 08/22/2019 08/23/2019 Date
177.95(c) 176.55(c) 178.65(c) 170(c) 168.8(c) Last
432 156 433 527 393 224 640 713 459 716 Volume
+2.33% -0.79% +1.19% -4.84% -0.71% Change
More quotes
Financials (SEK)
Sales 2019 13 585 M
EBIT 2019 4 104 M
Net income 2019 3 042 M
Debt 2019 7 562 M
Yield 2019 -
Sales 2020 14 799 M
EBIT 2020 4 869 M
Net income 2020 3 587 M
Debt 2020 3 657 M
Yield 2020 -
P/E ratio 2019 16,2x
P/E ratio 2020 13,9x
EV / Sales2019 4,21x
EV / Sales2020 3,60x
Capitalization 49 643 M
More Financials
Company
Swedish Orphan Biovitrum is specialized in the development, manufacturing and marketing of therapeutic products intended for the treatment of rare diseases (hemophilia, inflammatory and autoimmune illnesses, hereditary metabolic diseases, etc.). The turnover per source of income can be broken down... 
Sector
Pharmaceuticals
Calendar
10/31Earnings Release
More about the company
Surperformance© ratings of Swedish Orphan Biovitrum
Trading Rating : Investor Rating :
More Ratings
Latest news on SWEDISH ORPHAN BIOVITRUM
08/22ASTRAZENECA : to Buy US FDA Priority Review Voucher for $95 Million
DJ
08/22SWEDISH ORPHAN BIOVITRUM : Sobi has entered into agreement to sell Priority Revi..
AQ
07/18SWEDISH ORPHAN BIOVITRUM : Sobi completes acquisition of emapalumab and related ..
AQ
07/17WALL STREET STOCK EXCHANGE : Stocks Lower as Earnings Season Starts With Qualms ..
DJ
07/17WALL STREET STOCK EXCHANGE : U.S. Stocks Open Little Changed as Earnings Season ..
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17Global Stocks Wobble as Earnings Season Gets Under Way
DJ
07/17SWEDISH ORPHAN BIOVITRUM : Sobi publishes report for second quarter 2019
AQ
07/16SWEDISH ORPHAN BIOVITRUM : The Board of directors exercises authorisation for re..
PU
More news
Analyst Recommendations on SWEDISH ORPHAN BIOVITRUM
More recommendations
Sector news : Pharmaceuticals - NEC
08/23ALLERGAN : Form 8.3 -
DJ
08/23NOVARTIS : Delay on Data Manipulation Probed
DJ
08/23GLAXOSMITHKLINE : Achieves Positive Results Blood Cancer Treatment Study
DJ
08/22Alexion Up Nearly 8%, on Pace for Largest Percent Increase Since April 2018 -..
DJ
08/22ABBVIE : Form 8.3 -
DJ
More sector news : Pharmaceuticals - NEC
Chart SWEDISH ORPHAN BIOVITRUM
Duration : Period :
Swedish Orphan Biovitrum Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SWEDISH ORPHAN BIOVITRUM
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 229,17  SEK
Last Close Price 168,80  SEK
Spread / Highest target 86,6%
Spread / Average Target 35,8%
Spread / Lowest Target 7,82%
EPS Revisions
Managers
NameTitle
Guido Oelkers President & Chief Executive Officer
Sven Håkan Björklund Chairman
Anne Marie de Jonge Schuermans Head-Technical Operations
Henrik Stenqvist Chief Financial Officer
An van Es Johansson Vice President-Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
SWEDISH ORPHAN BIOVITRUM-12.54%5 158
JOHNSON & JOHNSON-1.02%346 443
ROCHE HOLDING LTD.11.71%236 383
MERCK AND COMPANY11.16%222 036
NOVARTIS18.13%204 408
PFIZER-19.63%194 029